The moment we all hoped we would never see is finally among us: the collision of coronavirus disease 2019 (COVID-19) and influenza (flu) season. Almost a y…
Read ArticleThe FDA approved a label update of UCB's Cimzia, or certolizumab pegol, to include new data showing a negligible to low risk for drug transfer through plac…
Read Article